<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30241207</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>15</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">2378-9506</ISSN>                <JournalIssue CitedMedium="Internet">                    <Issue>4</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of global oncology</Title>                <ISOAbbreviation>J Glob Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>Quality of Breast Cancer Treatment at a Rural Cancer Center in Rwanda.</ArticleTitle>            <Pagination>                <MedlinePgn>1-11</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1200/JGO.2016.008672</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">As breast cancer incidence and mortality rise in sub-Saharan Africa, it is critical to identify strategies for delivery of high-quality breast cancer care in settings with limited resources and few oncology specialists. We investigated the quality of treatments received by a cohort of patients with breast cancer at Butaro Cancer Center of Excellence (BCCOE), Rwanda's first public cancer center.</AbstractText>                <AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We reviewed medical records of all female patients diagnosed with invasive breast cancer at BCCOE between July 2012 and December 2013. We evaluated the provision of chemotherapy, endocrine therapy, surgery, and chemotherapy dose densities. We also applied modified international quality metrics and estimated overall survival using interval-censored analysis.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 150 patients, 28 presented with early-stage, 64 with locally advanced, and 53 with metastatic disease. Among potentially curable patients (ie, those with early-stage or locally advanced disease), 74% received at least four cycles of chemotherapy and 63% received surgery. Among hormone receptor-positive patients, 83% received endocrine therapy within 1 year of diagnosis. Fifty-seven percent of potentially curable patients completed surgery and chemotherapy and initiated endocrine therapy if indicated within 1 year of biopsy. Radiotherapy was not available. At the end of follow-up, 62% of potentially curable patients were alive, 24% were dead, and 14% were lost to follow-up.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Appropriate delivery of chemotherapy and endocrine therapy for breast cancer is possible in rural sub-Saharan African even without oncologists based on site. Performing timely surgery and ensuring treatment completion were key challenges after the opening of BCCOE. Further investigation should examine persistent quality gaps and the relationship between treatment quality and survival.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>O'Neil</LastName>                    <ForeName>Daniel S</ForeName>                    <Initials>DS</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Keating</LastName>                    <ForeName>Nancy L</ForeName>                    <Initials>NL</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dusengimana</LastName>                    <ForeName>Jean Marie V</ForeName>                    <Initials>JMV</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hategekimana</LastName>                    <ForeName>Vedaste</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Umwizera</LastName>                    <ForeName>Aline</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mpunga</LastName>                    <ForeName>Tharcisse</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shulman</LastName>                    <ForeName>Lawrence N</ForeName>                    <Initials>LN</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pace</LastName>                    <ForeName>Lydia E</ForeName>                    <Initials>LE</Initials>                    <AffiliationInfo>                        <Affiliation>Daniel S. O'Neil, Columbia University Medical Center, New York, NY; Nancy L. Keating and Lydia E. Pace, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Jean Marie V. Dusengimana, Partners in Health/Inshuti Mu Buzima, Rwinkwavu; Vedaste Hategekimana, Aline Umwizera, and Tharcisse Mpunga, Ministry of Health, Kigali, Rwanda; Lawrence N. Shulman, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>K24 CA181510</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2017</Year>                <Month>05</Month>                <Day>12</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Glob Oncol</MedlineTA>            <NlmUniqueID>101674751</NlmUniqueID>            <ISSNLinking>2378-9506</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):e35-42</RefSource>                <PMID Version="1">22156912</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Jun;139(3):863-72</RefSource>                <PMID Version="1">23771731</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2005 Feb;16(2):247-52</RefSource>                <PMID Version="1">15668278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1998 Sep;16(9):3137-47</RefSource>                <PMID Version="1">9738586</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Breast Cancer. 2005 Dec;6(5):412-20</RefSource>                <PMID Version="1">16381624</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Oncol. 2009 Dec;16(6):8-12</RefSource>                <PMID Version="1">20016741</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Niger J Clin Pract. 2012 Jul-Sep;15(3):265-9</RefSource>                <PMID Version="1">22960958</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Womens Health. 2010 Aug 09;2:77-82</RefSource>                <PMID Version="1">21072300</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Oncol Pract. 2015 Sep;11(5):370-1</RefSource>                <PMID Version="1">26384015</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2015 Jul;1(4):505-27</RefSource>                <PMID Version="1">26181261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Surg. 2013 Dec 19;13:59</RefSource>                <PMID Version="1">24354443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pan Afr Med J. 2014 Mar 10;17:182</RefSource>                <PMID Version="1">25392728</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Front Oncol. 2015 Jan 22;4:380</RefSource>                <PMID Version="1">25657930</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2008 Jul 8;99(1):63-7</RefSource>                <PMID Version="1">18577991</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pan Afr Med J. 2012;13:35</RefSource>                <PMID Version="1">23330026</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2014 Dec;23(6):821-8</RefSource>                <PMID Version="1">25282667</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg Oncol. 2015 Jul 19;13:220</RefSource>                <PMID Version="1">26187151</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ Open. 2016 Jan 04;6(1):e009905</RefSource>                <PMID Version="1">26729392</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Niger J Clin Pract. 2015 Mar-Apr;18(2):287-91</RefSource>                <PMID Version="1">25666009</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Dec 15;21(24):4524-31</RefSource>                <PMID Version="1">14673039</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Health Serv Res. 2015 Oct 15;15:471</RefSource>                <PMID Version="1">26471845</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2010 Sep;46(13):2344-56</RefSource>                <PMID Version="1">20675120</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Glob Oncol. 2016 Jan 20;2(2):76-82</RefSource>                <PMID Version="1">28717686</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2009 Jan;7(1):99-108</RefSource>                <PMID Version="1">19176210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2011 Apr;20 Suppl 2:S51-3</RefSource>                <PMID Version="1">21295480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2003 Apr 15;21(8):1431-9</RefSource>                <PMID Version="1">12668651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2010 Dec 15;127(12):2893-917</RefSource>                <PMID Version="1">21351269</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2008 Jul 20;26(21):3631-7</RefSource>                <PMID Version="1">18640941</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2010 Mar-Apr;16(2):206-7</RefSource>                <PMID Version="1">20136646</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2014 Aug 1;135(3):702-9</RefSource>                <PMID Version="1">24375396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA Oncol. 2016 Mar;2(3):330-9</RefSource>                <PMID Version="1">26659430</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):773-81</RefSource>                <PMID Version="1">22445001</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1990 Dec;8(12):1935-7</RefSource>                <PMID Version="1">2230885</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 Apr;14(4):e152-7</RefSource>                <PMID Version="1">23561746</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2014 Dec;14(12):815-21</RefSource>                <PMID Version="1">25355378</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Care. 2008 Aug;46(8):762-70</RefSource>                <PMID Version="1">18665055</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>23</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30241207</ArticleId>            <ArticleId IdType="doi">10.1200/JGO.2016.008672</ArticleId>            <ArticleId IdType="pmc">PMC6180813</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>